Whole-body MRI scans may not yield the kind of early detection rates their celebrity endorsers have led many to believe. 

NIH is hopeful the research will enable doctors to detect signs of stroke damage earlier, opening the door for them to initiate treatments in a timelier manner.

Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers. 

Despite its high accuracy, CTA can come with tradeoffs including requiring radiologists to review a high number of images looking for findings that can be subtle, increasing case complexity and workloads. 

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

The company describes Vivid Pioneer as its “most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet.” It includes new and improved AI capabilities and a compact design that is still fully functional in tight workspaces. 

The company is seeking approval for TLX250-CDx (brand name Zircaix), a novel PET (positron emission tomography) product geared toward kidney cancer. 

The system was built with patients in mind, and its compact design has the potential to expand access to the modality where it may have previously been lacking.